![Anti-Human Immunodeficiency Virus Type 1 Activity of the Nonnucleoside Reverse Transcriptase Inhibitor GW678248 in Combination with Other Antiretrovirals against Clinical Isolate Viruses and In Vitro Selection for Resistance]()
Anti-Human Immunodeficiency Virus Type 1 Activity of the Nonnucleoside Reverse Transcriptase Inhibitor GW678248 in Combination with Other Antiretrovirals against Clinical Isolate Viruses and In Vitro Selection for ResistanceHazen, R. J.; Harvey, R. J.; St. Clair, M. H.; Ferris, R. G.; Freeman, G. A.; Tidwell, J. H.; Schaller, L. T.; Cowan, J. R.; Short, S. A.; Romines, K. R.; Chan, J. H.; Boone, L. R. · Antimicrobial Agents and Chemotherapy · 2005